Phibro Animal Health (PAHC) Projected to Post Earnings on Wednesday

Phibro Animal Health (NASDAQ:PAHC) is expected to be releasing its Q1 2027 results after the market closes on Wednesday, November 4th. Analysts expect Phibro Animal Health to post earnings of $0.7830 per share and revenue of $382.42 million for the quarter. Phibro Animal Health has set its FY 2027 guidance at 3.410-3.590 EPS. Interested persons can find conference call details on the company’s upcoming Q1 2027 earnings results page for the latest details on the call scheduled for Thursday, November 5, 2026 at 9:00 AM ET.

Phibro Animal Health (NASDAQ:PAHC) last issued its earnings results on Wednesday, August 26th. The company reported $0.85 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.14. The firm had revenue of $396.75 million during the quarter, compared to analysts’ expectations of $381.18 million. On average, analysts expect Phibro Animal Health to post $3.49 EPS for the current fiscal year and $3.81 EPS for the next fiscal year.

Phibro Animal Health Trading Down 1.7%

Shares of Phibro Animal Health stock opened at $38.38 on Wednesday. The business’s fifty day moving average price is $36.79 and its 200 day moving average price is $41.13. Phibro Animal Health has a twelve month low of $28.25 and a twelve month high of $60.08.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Phibro Animal Health in a research note on Friday, September 11th. Zacks Research upgraded shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a report on Friday, September 18th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $47.67.

About Phibro Animal Health

Phibro Animal Health Corporation develops, manufactures and sells products designed to support the health, nutrition and productivity of food-producing animals. Its offerings include animal health products, vaccines, medicated feed additives, nutritional specialties and performance products used in livestock, poultry and aquaculture.

The company’s products are intended to help prevent and manage disease, improve animal well-being and support efficient food production. Phibro serves producers, veterinarians, feed manufacturers and distributors through a portfolio that includes pharmaceuticals, vaccines, mineral and nutritional supplements, and other feed and water solutions.

Phibro Animal Health markets its products internationally across a broad range of geographic regions, including North America, Latin America, Europe, Asia-Pacific and other global markets.